Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Dermatology · Folliculitis Decalvans–Lichen Planopilaris Overlap Syndrome

What Is FD-LPP Overlap Syndrome? Meaning and Signs

At a Glance

FD-LPP overlap syndrome is a form of scarring hair loss with features of both folliculitis decalvans and lichen planopilaris. It can cause pustules, crusting, scaling, redness, and permanent hair loss, so treatment focuses on controlling active inflammation and protecting remaining follicles.

When you are diagnosed with folliculitis decalvans–lichen planopilaris overlap syndrome (often shortened to FD-LPP overlap), it means your condition shows features of both folliculitis decalvans (FD) and lichen planopilaris (LPP). Rather than meaning you have two completely unrelated diseases—or that your condition is contagious or caused by poor hygiene—this diagnosis describes a specific pattern. In this pattern, your scalp exhibits a mixture of the neutrophilic inflammation (driven by neutrophils, a type of white blood cell common in FD) and the lichenoid or lymphocytic inflammation (driven by lymphocytes, another type of immune cell common in LPP) [1][2]. This overlap can happen all at once, or your symptoms may shift from one pattern to the other over time [2][3].

The medical community is still studying this condition, meaning diagnostic criteria are not yet uniform [1]. You may hear overlapping terms like the “FD-LPP phenotypic spectrum” or a “biphasic presentation,” which clinicians use to describe this mixed pattern of inflammation and scarring hair loss [4]. Ask your dermatologist to explain exactly what the label means for your specific case.

Setting Realistic Goals: Scarring vs. Active Inflammation

Before discussing signs and treatments, it is important to understand the goal of care. FD-LPP overlap is a form of scarring alopecia (scarring hair loss). This means that once a hair follicle is completely destroyed and replaced by a scar, hair will not regrow in that specific spot [5].

The primary goal of treatment is to quiet the active inflammation, relieve symptoms (like pain, drainage, or itching), and protect your remaining hair follicles from permanent destruction [5].

Clinical and Trichoscopic Clues

Because this syndrome bridges two conditions, the physical signs on the scalp are a mix of both. Your dermatologist will look for clues using trichoscopy (a magnified examination of the scalp). These visual clues help guide the evaluation, though they do not independently confirm the overlap diagnosis [6][3].

  • FD-like signs: You may have follicular pustules (pus-filled bumps), crusts, and polytrichia (often called “tufted hairs,” where multiple hairs emerge from a single follicle opening) [3][7]. Trichoscopy often reveals yellowish tubular scale and redness [6].
  • LPP-like signs: You may also develop perifollicular erythema (redness around the hair follicle) and thick white scaling or casts hugging the base of the hairs [3][7]. Trichoscopy might show target-like blue-gray dots [6].

In one observational study of 31 patients with this overlap, hair tufting combined with perifollicular white scaling was reported in every case, though individual symptoms can vary widely [3]. The overlap can present right away, or classic FD can transition to this mixed presentation over a period of years [3].

The Role of a Scalp Biopsy

FD and LPP are often suspected based on the clinical examination and trichoscopy. A scalp biopsy is not always strictly required, but it is often used when the diagnosis is uncertain, symptoms are atypical, or your doctor needs to reliably rule out other conditions [8][9].

When an expert dermatopathologist (a doctor specializing in reading skin tissue samples) analyzes the tissue, they might see a highly variable picture:

  • Mixed inflammation: The biopsy may show a combination of different inflammatory immune cells (lymphocytes, histiocytes, and plasma cells) and concentric scarring around the follicles [1][4].
  • Absence of expected cells: Surprisingly, neutrophils (the main cells usually seen in FD) may be scarce or completely absent in the biopsy [1]. Inflammation can be patchy, and a biopsy might simply miss the most active area. Furthermore, previous treatments or the age of the lesion can alter the microscopic appearance [10][11]. Therefore, the absence of neutrophils in a single sample does not rule out FD-like activity.

Because microscopic findings can be subtle, the dermatopathologist will often examine the biopsy from multiple angles (vertical and transverse sections) and carefully correlate the findings with your clinical history [12][13].

Individualized Treatment Approach

Because FD-LPP overlap is complex, there is no universally accepted, one-size-fits-all treatment regimen [1]. Evidence comes largely from observational reports and small case series. Your doctor will tailor your treatment based on which inflammatory pattern is most active at any given time [3].

  • Targeting FD-like activity: If crusting and pustules are driving the disease, your doctor may prescribe oral antibiotics [1][5]. These are used not just to clear bacterial overgrowth, but primarily for their strong anti-inflammatory effects [1][5].
  • Targeting LPP-like activity: To address the scaling and redness, topical or intralesional corticosteroids (steroid injections) are frequently used, sometimes alongside other immune-modifying medications [3][14].

Important Treatment Considerations

  • Medical Supervision: Never start leftover antibiotics or strong steroids without medical advice.
  • Side Effects: Long-term use of topical or injected steroids can cause skin thinning (atrophy), while oral medications require laboratory monitoring for drug interactions and other systemic side effects [14][15].
  • Relapse and Monitoring: This condition can be stubborn, and clinical relapses are common even after successful initial treatment [3][4]. Ongoing monitoring is essential. Contact your doctor if you experience rapid worsening of pain, spreading redness, extensive drainage, or a fever, as these may signal a flare or secondary infection that needs immediate attention.

Common questions in this guide

What does an FD-LPP overlap syndrome diagnosis mean?
It means the scalp has features of both folliculitis decalvans and lichen planopilaris. The inflammation may involve different immune cells and can appear as a mixed pattern at the same time or shift from one pattern to the other over time.
Is FD-LPP overlap contagious or caused by poor hygiene?
No. This diagnosis describes a pattern of inflammation and scarring hair loss, not a condition that spreads from person to person, and it is not caused by poor hygiene.
What scalp symptoms can occur with FD-LPP overlap?
Possible findings include pus-filled follicular bumps, crusts, tufted hairs, redness around follicles, and thick white scale around the hairs. Pain, itching, or drainage may also occur, and the pattern can change over time.
Do I need a scalp biopsy to diagnose FD-LPP overlap?
Not always, because a dermatologist may recognize the pattern from an examination and trichoscopy. A biopsy can help when the diagnosis is uncertain, symptoms are unusual, or other conditions need to be ruled out; a single sample may miss patchy active inflammation.
Can hair grow back after FD-LPP overlap causes hair loss?
Hair cannot regrow from a follicle that has been completely destroyed and replaced by scar tissue. Treatment aims to calm active inflammation, relieve symptoms, and protect follicles that are still viable.
How is FD-LPP overlap syndrome treated?
There is no single treatment plan for everyone. Doctors may use oral antibiotics for FD-like pustules and crusting, and topical or injected corticosteroids for LPP-like scaling and redness, with treatment adjusted to the most active pattern and monitored for side effects.
Can FD-LPP overlap come back after treatment?
Yes, relapses are common even after initial improvement, so ongoing dermatology follow-up is important. Rapidly worsening pain, spreading redness, extensive drainage, or fever should be reported promptly because they may indicate a flare or secondary infection.

Get notified when new evidence is published on Quinquaud folliculitis decalvans.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (15)
  1. 1

    Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum-A Series of 7 New Cases With Focus on Histopathology.

    Egger A, Stojadinovic O, Miteva M

    The American Journal of dermatopathology 2020; (42(3)):173-177 doi:10.1097/DAD.0000000000001595.

    PMID: 31855586
  2. 2

    Folliculitis decalvans and lichen planopilaris phenotypic spectrum: a case series of biphasic clinical presentation and theories on pathogenesis.

    Yip L, Barrett TH, Harries MJ

    Clinical and experimental dermatology 2020; (45(1)):63-72 doi:10.1111/ced.13989.

    PMID: 31017678
  3. 3

    Clinical Characterization and Treatment Response of Folliculitis Decalvans Lichen Planopilaris Phenotypic Spectrum: A Unicentre Retrospective Series of 31 Patients.

    Melián-Olivera A, Moreno-Arrones Ó, Burgos-Blasco P, et al.

    Acta dermato-venereologica 2024; (104()):adv12373 doi:10.2340/actadv.v104.12373.

    PMID: 38372472
  4. 4

    Paediatric-Onset Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum: Is It a Different Disease?

    Awad A, Kho YC, Asfour L, et al.

    Experimental dermatology 2026; (35(1)):e70197 doi:10.1111/exd.70197.

    PMID: 41496469
  5. 5

    Management of folliculitis decalvans: The EADV task force on hair diseases position statement.

    Waśkiel-Burnat A, Starace M, Iorizzo M, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2025; (39(8)):1385-1394 doi:10.1111/jdv.20687.

    PMID: 40230058
  6. 6

    Evaluation of a Handheld Dermatoscope in Clinical Diagnosis of Primary Cicatricial Alopecias.

    Karadag Köse Ö, Güleç AT

    Dermatology and therapy 2019; (9(3)):525-535 doi:10.1007/s13555-019-0304-3.

    PMID: 31190216
  7. 7

    Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum: A Case Report.

    Zhang X, Zhu M, Zhou J, et al.

    Clinical, cosmetic and investigational dermatology 2022; (15()):993-996 doi:10.2147/CCID.S365566.

    PMID: 35677221
  8. 8

    Lichen Planopilaris with Pustules: A Diagnostic Challenge.

    Morais KL, Martins CF, Anzai A, et al.

    Skin appendage disorders 2018; (4(2)):61-66 doi:10.1159/000478268.

    PMID: 29765960
  9. 9

    Lichen planopilaris and frontal fibrosing alopecia: review and update of diagnostic and therapeutic features.

    Fechine COC, Valente NYS, Romiti R

    Anais brasileiros de dermatologia 2022; (97(3)):348-357 doi:10.1016/j.abd.2021.08.008.

    PMID: 35379508
  10. 10

    Histopathologic and dermoscopic features of 42 cases of folliculitis decalvans: A case series.

    Uchiyama M, Harada K, Tobita R, et al.

    Journal of the American Academy of Dermatology 2021; (85(5)):1185-1193 doi:10.1016/j.jaad.2020.03.092.

    PMID: 32272176
  11. 11

    Cross-sectional study to evaluate the utility of elastic tissue staining in primary cicatricial alopecia.

    Vishwanath T, Dhurat R

    Journal of clinical pathology 2024; (77(11)):737-742 doi:10.1136/jcp-2022-208745.

    PMID: 37553248
  12. 12

    Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum-A Series of Four Patients.

    Shanmugakumar S, Rai R, Gurusamy UM

    Indian journal of dermatology 2026; (71(1)):85 doi:10.4103/ijd.ijd_1064_23.

    PMID: 41585834
  13. 13

    Line Field Confocal Optical Coherence Tomography (LC-OCT) Features of Primary Cicatricial Alopecias.

    Traini DO, Palmisano G, Ciobotariu I, et al.

    International journal of dermatology 2026; (65(8)):1641-1646 doi:10.1111/ijd.70266.

    PMID: 41532173
  14. 14

    Management of classic lichen planopilaris: The EADV task force on hair diseases position statement.

    Seyed Jafari SM, Starace M, Katoulis A, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2026; (40(8)):1306-1317 doi:10.1111/jdv.70379.

    PMID: 41848299
  15. 15

    Treatment of Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective, Real-Life Analysis in a Tertiary Center in Germany.

    Stege H, Haist M, Schultheis M, et al.

    Journal of clinical medicine 2024; (13(16)) doi:10.3390/jcm13164947.

    PMID: 39201087

This page is for informational purposes only and does not constitute medical advice about FD-LPP overlap syndrome. A dermatologist and, when needed, a dermatopathologist should interpret your symptoms, biopsy, and treatment plan.